- Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Scientific reports. 2020;10(1):1-11.
- 2. Dastah S, Babaei S. Effect of aquatic training on serum Fetuin-A, ANGPTL4 and FGF21 levels in type 2 diabetic obese women. Journal of Applied Health Studies in Sport Physiology. 2021;8(2):51-60. (In Persion)
- 3. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice. 2019;157:107843. (In Persion)
- 4. Dastah S, Tofighi A, Azar JT, Alivand M. Aerobic exercise leads to upregulation of Mir-126 and angiogenic signaling in the heart tissue of diabetic rats. Gene Reports. 2020;21:100914. (In Persion)
- 5. Froozandeh E, Tofighi A, Tolouei Azar J. Furin, CTRP-12, TNF-α and Lipid Profile Changes during 8 Weeks of Aerobic Interval and Resistance Training in Women with Type 2 Diabetes. Sport Physiology & Management Investigations. 2020;12(3):25-40. (In Persion)
- 6. Dastah S, Tofighi A, Bonab SB. The effect of aerobic exercise on the expression of mir-126 and related target genes in the endothelial tissue of the cardiac muscle of diabetic rats. Microvascular Research. 2021;138:104212. (In Persion)
- 7. Wang D, Zhang Y, Shen C. Research update on the association between SFRP5, an anti‐inflammatory adipokine, with obesity, type 2 diabetes mellitus and coronary heart disease. Journal of cellular and molecular medicine. 2020;24(5):2730-5.
- 8. Blüher M. The inflammatory process of adipose tissue. Pediatric endocrinology reviews: PER. 2008;6(1):24-31.
- 9. Hu Z, Deng H, Qu H. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance. Diabetes research and clinical practice. 2013;99(3):391-5.
- 10. Ouchi N, Higuchi A, Ohashi K, Oshima Y, Gokce N, Shibata R, et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science. 2010;329(5990):454-7.
- 11. Hu W, Li L, Yang M, Luo X, Ran W, Liu D, et al. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. The Journal of Clinical Endocrinology & Metabolism. 2013;98(1):290-8.
- 12. Schulte DM, Müller N, Neumann K, Oberhäuser F, Faust M, Güdelhöfer H, et al. Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects. PloS one. 2012;7(2):e32437.
- 13. Carstensen M, Herder C, Kempf K, Erlund I, Martin S, Koenig W, et al. Sfrp5 correlates with insulin resistance and oxidative stress. European journal of clinical investigation. 2013;43(4):350-7.
- 14. He X, Ma H. Correlation between circulating levels of secreted frizzled-related protein 5 and type 2 diabetic patients and subjects with impaired-glucose regulation. Diabetes, Metabolic Syndrome and Obesity. 2020:1243-50.
- 15. Rulifson IC, Majeti JZ, Xiong Y, Hamburger A, Lee KJ, Miao L, et al. Inhibition of secreted frizzled-related protein 5 improves glucose metabolism. American Journal of Physiology-Endocrinology and Metabolism. 2014;307(12):E1144-E52.
- 16. Mori H, Prestwich TC, Reid MA, Longo KA, Gerin I, Cawthorn WP, et al. Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. The Journal of clinical investigation. 2012;122(7):2405-16.
- 17. Thent ZC, Das S, Henry LJ. Role of exercise in the management of diabetes mellitus: the global scenario. PloS one. 2013;8(11):e80436.
- 18. Joummy AJ, Suppiah PK, Samsir MS. The Effect of High-Intensity Intermittent Functional Training Towards The Aerobic Fitness of Youth Badminton Players. Malaysian Journal of Movement, Health & Exercise. 2020;9(1):149-58.
- 19. Amamou T, Normandin E, Pouliot J, Dionne I, Brochu M, Riesco E. Effect of a high-protein energy-restricted diet combined with resistance training on metabolic profile in older individuals with metabolic impairments. The Journal of nutrition, health and aging. 2017;21(1):67-74.
- 20. Mir E, Moazzami M, Bijeh N, Hakak Dokht E, Rahimi N. Changes in SFRP5, WNT5A, HbA1c, BMI, PBF, and insulin resistance in men with type 2 diabetes after 12 weeks of combined exercise (HIIT and resistance). International Journal of Diabetes in Developing Countries. 2020;40:248-54.
- 21. Fayaz E, Damirchi A, Zebardast N, Babaei P. Cinnamon extract combined with high-intensity endurance training alleviates metabolic syndrome via non-canonical WNT signaling. Nutrition. 2019;65:173-8. (In Persion)
- 22. Łysakowska P, Sobota A, Wirkijowska A. Medicinal mushrooms: their bioactive components, nutritional value and application in functional food production—a review. Molecules. 2023;28(14):5393.
- 23. Keypour S, Riahi H, Rafati H. A review on the biological active compounds and medicinal properties of Ganoderma lucidum. Journal of Medicinal Plants. 2013;12(46):13-24. (In Persion)
- 24. Meneses ME, Martínez-Carrera D, Torres N, Sánchez-Tapia M, Aguilar-López M, Morales P, et al. Hypocholesterolemic properties and prebiotic effects of Mexican Ganoderma lucidum in C57BL/6 mice. PloS one. 2016;11(7):e0159631.
- 25. Xiao C, Wu Q, Zhang J, Xie Y, Cai W, Tan J. Antidiabetic activity of Ganoderma lucidum polysaccharides F31 down-regulated hepatic glucose regulatory enzymes in diabetic mice. Journal of ethnopharmacology. 2017;196:47-57.
- 26. Liu Y, Li Y, Zhang W, Sun M, Zhang Z. Hypoglycemic effect of inulin combined with ganoderma lucidum polysaccharides in T2DM rats. Journal of Functional Foods. 2019;55:381-90.
- 27. Liang H, Pan Y, Teng Y, Yuan S, Wu X, Yang H, et al. A proteoglycan extract from Ganoderma Lucidum protects pancreatic beta-cells against STZ-induced apoptosis. Bioscience, Biotechnology, and Biochemistry. 2020;84(12):2491-8.
- 28. Jia J, Zhang X, Hu Y-S, Wu Y, Wang Q-Z, Li N-N, et al. Evaluation of in vivo antioxidant activities of Ganoderma lucidum polysaccharides in STZ-diabetic rats. Food Chemistry. 2009;115(1):32-6.
- 29. Chow S-C, Shao J, Wang H, Lokhnygina Y. Sample size calculations in clinical research: chapman and hall/CRC; 2017.
- 30. Nawrocka A, Mynarski W. Objective assessment of adherence to global recommendations on physical activity for health in relation to spirometric values in nonsmoker women aged 60–75 years. Journal of aging and physical activity. 2017;25(1):123-7.
- 31. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. The American journal of clinical nutrition. 1982;36(5):936-42.
- 32. Kannel WB, Sorlie P. Some health benefits of physical activity: the Framingham Study. Archives of internal medicine. 1979;139(8):857-61.
- 33. Sartor CD, Watari R, Pássaro AC, Picon AP, Hasue RH, Sacco IC. Effects of a combined strengthening, stretching and functional training program versus usual-care on gait biomechanics and foot function for diabetic neuropathy: a randomized controlled trial. BMC musculoskeletal disorders. 2012;13:1-10.
- 34. Fusco A, Knutson C, King C, Mikat RP, Porcari JP, Cortis C, et al. Session RPE during prolonged exercise training. International journal of sports physiology and performance. 2020;15(2):292-4.
- 35. Klupp NL, Kiat H, Bensoussan A, Steiner GZ, Chang DH. A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome. Scientific reports. 2016;6(1):29540.
- 36. Ghaffarpour M, Houshiar A, Kianfar H. Household of scales guide, conversion coefficients and percent of edible food. Tehran, Publication of Agricultural Sciences. 2000;25:24-9. (In Persion)
- 37. Yin C, Chu H, Li H, Xiao Y. Plasma Sfrp5 and adiponectin levels in relation to blood pressure among obese children. Journal of human hypertension. 2017;31(4):284-91.
- 38. Teliewubai J, Bai B, Zhou Y, Lu Y, Yu S, Chi C, et al. Association of asymptomatic target organ damage with secreted frizzled related protein 5 in the elderly: the Northern Shanghai Study. Clinical Interventions in Aging. 2018:389-95.
- 39. Catalán V, Gómez-Ambrosi J, Rodríguez A, Pérez-Hernández AI, Gurbindo J, Ramírez B, et al. Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation. The Journal of Clinical Endocrinology & Metabolism. 2014;99(8):E1407-E17.
- 40. Bilkovski R, Schulte D, Oberhauser F, Mauer J, Hampel B, Gutschow C, et al. Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans. International journal of obesity. 2011;35(11):1450-4.
- 41. Adabimohazab R, Garfinkel A, Milam EC, Frosch O, Mangone A, Convit A. Does inflammation mediate the association between obesity and insulin resistance? Inflammation. 2016;39:994-1003. (In Persion)
- 42. Gustafson B, Hammarstedt A, Hedjazifar S, Smith U. Restricted adipogenesis in hypertrophic obesity: the role of WISP2, WNT, and BMP4. Diabetes. 2013;62(9):2997-3004.
- 43. Fuster JJ, Zuriaga MA, Ngo DT-M, Farb MG, Aprahamian T, Yamaguchi TP, et al. Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes. 2015;64(4):1235-48.
- 44. Safarzadeh A, Ariania M, Talebi E. Effects of eight weeks of resistance training on serum SFRP5 concentration in obese men. Journal of Sports and Biomotor Sciences. 2016;8(16):54-61. Effects of eight weeks of resistance training on serum SFRP5 concentration in obese men. Journal of Sports and Biomotor Sciences. 2016;8(16):54-61
- 45. Yu F, Teng Y, Li J, Yang S, Zhang Z, He Y, et al. Effects of a Ganoderma lucidum Proteoglycan on Type 2 Diabetic Rats and the Recovery of Rat Pancreatic Islets. ACS omega. 2023;8(19):17304-16.
- 46. Zhang H-N, He J-H, Yuan L, Lin Z-B. In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage. Life sciences. 2003;73(18):2307-19.
|
